Cover of book: Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes
Book Titles Open Access Full access

Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes

Authors:
Publisher:
 2018

Summary

Biopatents frequently disclose sequences of polypeptides and nucleic acids in the written description. The claims often cover a homology range surrounding the disclosed sequence to get a broader protection. However, homology claims face a hurdle that they may lack support by the written description. The Supreme Court of China ruled that homology claims lack support, but a further limitation by species of origin satisfies this requirement. This study explains that homology per se should have formed the essence of such disputes. Homology dictates the skilled person’s confidence on the functionality of unknown sequences, and is involved in multiple patentability requirements. Thus, the assessment of support is not an isolated matter. Disparity of different requirements creates an unclaimable gap, and constitutes a discrimination to biotechnology. An appropriate test for the support requirement is thus furnished to confer a scope of protection commensurating to the technical contribution.



Bibliographic data

Copyright year
2018
ISBN-Print
978-3-8487-5021-4
ISBN-Online
978-3-8452-9271-7
Publisher
Nomos, Baden-Baden
Series
Munich Intellectual Property Law Center - MIPLC Studies
Volume
32
Language
English
Pages
72
Product type
Book Titles

Table of contents

ChapterPages
  1. Titelei/InhaltsverzeichnisPages 1 - 12 Download chapter (PDF)
  2. I. IntroductionPages 13 - 15 Download chapter (PDF)
  3. Download chapter (PDF)
    1. A. The Glucoamylase
    2. B. The Patent
    3. C. The Proceedings on Patent Infringement
      1. 1. The Patent Reexamination Board
      2. 2. The Courts of First Instance and Second Instance
      3. 3. The Supreme Court
    4. E. Comments – a Good Will, but also a “Chicken Rib”
  4. Download chapter (PDF)
    1. A. Supporting Data for Homology Claims is Not Necessary for the Patent Law
    2. B. Supporting Data for Homology Claims is an Overwhelming Burden
      1. 1. The Homology Language
      2. 2. The Technical Meaning of Homology
    3. D. Species of Origin is Not an Effective Limitation
    4. E. Concluding Remarks
  5. Download chapter (PDF)
    1. A. Inventive Step and Support are One-Dimensionally Aligned by Homology
    2. B. Disparity in Views on Homology Creates an Unclaimable Gap
    3. C. The Unclaimable Gap May Constitute a Discrimination
    4. D. Downregulating Inventive Step is Not a Feasible Option
  6. Download chapter (PDF)
    1. A. Sufficient Disclosure and Support Have Different “Prior Art”
    2. B. Novozymes Tests Support Using the Standard of Sufficient Disclosure
    3. C. An Example Test Given by the EWHC
    4. D. On Non-Working Variants – How to Avoid a “Negative Gap”?
  7. VI. ConclusionPages 64 - 66 Download chapter (PDF)
  8. Annex I: Sequences of Cytochrome c from 17 Different SpeciesPages 67 - 68 Download chapter (PDF)
  9. List of Works CitedPages 69 - 72 Download chapter (PDF)

Bibliography (29 entries)

  1. Berg J, Tymoczko J and Stryer L, Biochemistry (2007) Open Google Scholar
  2. Burk DL and Lemley MA, ‘Is Patent Law Technology-Specific?’ (2002) 17 Berkeley Technology Law Journal 1155 Open Google Scholar doi.org/10.2139/ssrn.349761
  3. Chahine KG, ‘Enabling DNA and Protein Composition Claims: Why Claiming Biological Equivalents Encourages Innovation’ (1997) 25 AIPLA QJ 333 Open Google Scholar
  4. Cremers K and others, ‘Invalid but Infringed? An Analysis of the Bifurcated Patent Litigation System’ (2016) 131 Journal of Economic Behavior and Organization 218 Open Google Scholar doi.org/10.1016/j.jebo.2016.08.005
  5. Dinarello C a, ‘Historical Review of Cytokines’ (2007) 37 European Journal of Immunology S34 Open Google Scholar doi.org/10.1002/eji.200737772
  6. Djamei A and others, ‘Trojan Horse Strategy in Agrobacterium Transformation: Abusing MAPK Defense Signaling’ (2007) 318 Science 453 Open Google Scholar doi.org/10.1126/science.1148110
  7. French S and Robson B, ‘What Is a Conservative Substitution?’ (1983) 19 Journal of Molecular Evolution 171 Open Google Scholar doi.org/10.1007/BF02300754
  8. Furniss CSM, Williamson G and Kroon PA, ‘The Substrate Specificity and Susceptibility to Wheat Inhibitor Proteins of Penicillium funiculosum Xylanases from a Commercial Enzyme Preparation’ (2005) 85 Journal of the Science of Food and Agriculture 574 Open Google Scholar doi.org/10.1002/jsfa.1984
  9. Fusco S, ‘TRIPS Non-Discrimination Principle: Are Alice and Bilski Really the End of NPEs?’ <https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2653463> Open Google Scholar
  10. Luo G, Romance of the Three Kingdoms (XinXii-GD Publishing 2016) Open Google Scholar
  11. Heller MA and Eisenberg RS, ‘Can Patents Deter Innovation? The Anticommons in Biomedical Research’ (1998) 280 Science 698 Open Google Scholar doi.org/10.1126/science.280.5364.698
  12. Hodges RA, ‘Black Box Biotech Inventions: When a “Mere Wish or Plan” Should Be Considered an Adequate Description of the Invention’ (2001) 17 Georgia State University Law Review Open Google Scholar
  13. Kumar P and Satyanarayana T, ‘Microbial Glucoamylases: Characteristics and Applications’ (2009) 29 Critical Reviews in Biotechnology 225 Open Google Scholar doi.org/10.1080/07388550903136076
  14. Li C-X and others, ‘Genome Sequencing and Analysis of Talaromyces pinophilus Provide Insights into Biotechnological Applications’ (2017) 7 Scientific Reports 490 Open Google Scholar doi.org/10.1038/s41598-017-00567-0
  15. Lucas JM, ‘The Doctrine of Simultaneous Conception and Reduction to Practice in Biotechnology: A Double Standard for the Double Helix’ (1998) 26 AIPLA Quarterly Journal Open Google Scholar
  16. Marín-Navarro J and Polaina J, ‘Glucoamylases: Structural and Biotechnological Aspects’ (2011) 89 Applied Microbiology and Biotechnology 1267 Open Google Scholar doi.org/10.1007/s00253-010-3034-0
  17. Nielsen BR, Nielsen RI and Lehmbeck J, ‘Thermostable Glucoamylase’ <https://encrypted.google.com/patents/EP1032654B1?cl=nl> Open Google Scholar
  18. Prajapati VS, Trivedi UB and Patel KC, ‘Kinetic and Thermodynamic Characterization of Glucoamylase from Colletotrichum sp. KCP1’ (2014) 54 Indian Journal of Microbiology 87 Open Google Scholar doi.org/10.1007/s12088-013-0413-0
  19. Pearson WR, ‘An Introduction to Sequence Similarity (“homology”) Searching’ [2013] Current Protocols in Bioinformatics Open Google Scholar doi.org/10.1002/0471250953.bi0301s42
  20. Price D, ‘Energy and Human Evolution’ (1995) 16 Population and Environment 301 Open Google Scholar doi.org/10.1007/BF02208116
  21. Schrammeijer B and others, ‘Interaction of the Virulence Protein VirF of Agrobacterium tumefaciens with Plant Homologs of the Yeast Skp1 Protein’ (2001) 11 Current Biology 258 Open Google Scholar doi.org/10.1016/S0960-9822(01)00069-0
  22. Strahler AN, Science and Earth History: The Evolution/creation Controversy (Prometheus Books 1987) Open Google Scholar
  23. Vergunst AC and others, ‘Positive Charge Is an Important Feature of the C-Terminal Transport Signal of the VirB/D4-Translocated Proteins of Agrobacterium’ (2005) 102 Proceedings of the National Academy of Sciences 832 Open Google Scholar doi.org/10.1073/pnas.0406241102
  24. Woese CR and Fox GE, ‘Phylogenetic Structure of the Prokaryotic Domains: The Primary Kingdoms’ (1977) 74 Proceedings of the National Academy of Sciences, USA 5088 Open Google Scholar doi.org/10.1073/pnas.74.11.5088
  25. Wu W, ‘effective limitation by microbial species of origin in patent claims’ China Intellectual Property News (3 May 2017) Open Google Scholar
  26. Yamamoto F, ‘Review: ABO Blood Group system—ABH Oligosaccharide Antigens, Anti-A and Anti-B,A and B Glycosyltransferases, and ABO Genes’ (2004) 20 Immunohematology 3 Open Google Scholar
  27. Yang Z, New insights on Intellectual Property Law – Detailed Analysis of the Theories and Practice (Sichuan University Press, 2009) Open Google Scholar
  28. —— A Study on the Scope of Patent Protection (Sichuan University Press, 2013) Open Google Scholar
  29. Zhu W, ‘After the Twists and Turns, Novozymes’ Protein Patent Is Finally Maintained’ China Intellectual Property News (15 March 2017) Open Google Scholar

Similar publications

from the topics "European Law & International Law & Comparative Law"
Cover of book: Der Volkseinwand
Book Titles No access
Florian Feigl
Der Volkseinwand
Cover of book: Wie fördert die EU Menschenrechte in Drittstaaten?
Book Titles No access
Dennis Traudt
Wie fördert die EU Menschenrechte in Drittstaaten?
Cover of book: Future-Proofing in Public Law
Edited Book No access
Nicole Koblenz LL.M., Nicholas Otto, Gernot Sydow
Future-Proofing in Public Law